199 Enhanced immune responses in human breast and colon cancer following checkpoint therapy in a CD34+ stem cell humanized NCG (HuCD34NCG) mouse model
Main Authors: | Christoph Eberle, Jenny Rowe, Ann Fiore, Robert Mihalek, Stephen Festin |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2020-11-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Similar Items
-
1449 NCG-M is a triple immunodeficient mouse with increased reconstitution of human myeloid cell populations for use in immunotherapy preclinical research
by: Christoph Eberle, et al.
Published: (2023-11-01) -
1452 NCG-X is a triple immunodeficient mouse capable of being immune humanized without irradiation for use in immunotherapy preclinical research
by: Christoph Eberle, et al.
Published: (2023-11-01) -
The multitrace matrix model: An alternative to Connes NCG and IKKT model in 2 dimensions
by: Badis Ydri
Published: (2016-12-01) -
The Non-party Caretaker Government (NCG) for conducting elections: Bangladesh as a case study
by: Quddus, S. M. Abdul, et al.
Published: (2011) -
NCG-TSM: A Noncooperative Game for the Taxi Sharing Model in Urban Road Networks
by: Liping Yan, et al.
Published: (2023-01-01)